International Business Machines Corp (IBM) concluded trading on Thursday at a closing price of $264.74, with 4.88 million shares of worth about $1.29 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 35.95% during that period and on February 20, 2025 the price saw a gain of about 0.16%. Currently the company’s common shares owned by public are about 924.64M shares, out of which, 923.60M shares are available for trading.
Stock saw a price change of 3.49% in past 5 days and over the past one month there was a price change of 18.05%. Year-to-date (YTD), IBM shares are showing a performance of 20.43% which increased to 41.09% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $162.62 but also hit the highest price of $265.72 during that period. The average intraday trading volume for International Business Machines Corp shares is 4.41 million. The stock is currently trading 5.69% above its 20-day simple moving average (SMA20), while that difference is up 12.70% for SMA50 and it goes to 28.19% higher than SMA200.
International Business Machines Corp (NYSE: IBM) currently have 924.64M outstanding shares and institutions hold larger chunk of about 63.53% of that.
The stock has a current market capitalization of $244.79B and its 3Y-monthly beta is at 0.73. PE ratio of stock for trailing 12 months is 41.27, while it has posted earnings per share of $6.41 in the same period. Its PEG reads 7.79 and has Quick Ratio of 0.97 while making debt-to-equity ratio of 2.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IBM, volatility over the week remained 1.57% while standing at 2.28% over the month.
Stock’s fiscal year EPS is expected to rise by 3.76% while it is estimated to increase by 6.67% in next year. EPS is likely to grow at an annualized rate of 5.30% for next 5-years, compared to annual growth of -9.45% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on February 11, 2025 offering an Outperform rating for the stock and assigned a target price of $320 to it. On October 02, 2024, DZ Bank Downgrade their recommendations, while on June 24, 2024, Goldman Initiated their ratings for the stock with a price target of $200. Stock get an Underperform rating from Exane BNP Paribas on May 02, 2024.
